A
Ativa Medical
Developing lab-quality, high-value Point-of-Care (POC) testing medical diagnostic products
At a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Saint Paul, United States
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 76.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Testing, Risk Management, Biotechnology, Point of Care, Health Diagnostics, Biotech and Pharma, Hard Tech, medical testing, DT and LS
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Ativa Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2017 | $9.5M | $38M | Undisclosed | — |
| SERIES B✓Equity / VC | Sep 2015 | $15M | $60M | Hermed Capital · LabCorp · Ping An Ventures | — |
Growth signals
Latest recorded traffic for Ativa Medical is 720 monthly website visits, down 1.4% over the last three months. Ativa Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Ping An Ventures- HCHermed Capital
LabCorp
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ativa Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ativa Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







